Award
National Cancer Institute 4R00CA296940-02
Adverse gut microbiome promotes resistance immune checkpoint inhibitors via chronic inflammation
Recipient
National Cancer Institute (NCI)
Award Amount
$248,658.00
Ceiling
$248,658.00
Awarded
April 17, 2026
Identifier
4R00CA296940-02
NIH/NCI awarded a research project on the role of adverse gut microbiome in resistance to immune checkpoint inhibitors, involving patient sample analysis and mouse model studies.
Description
This is a research project funded by the NIH/NCI focusing on microbiome and cancer immunotherapy. The project involves longitudinal analysis of patient samples, spatial transcriptomics, and immune system reprogramming in mouse models.